ask="N/A"
ask_size="N/A"
average_daily_volume="31005"
bid="0.35"
bid_size="500"
book_value="0.28"
change="+0.01"
change_from_200_day_moving_average="-0.25"
change_from_50_day_moving_average="-0.04"
change_from_52_week_high="-0.96"
change_From_52_week_low="0.10"
change_in_percent="+1.67%"
close="0.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="9122000"
high="0.64"
high_52_weeks="1.57"
last_trade_date="2/9/2017"
last_trade_price="0.61"
last_trade_size="400"
last_trade_time="4:00pm"
low="0.55"
low_52_weeks="0.51"
market_capitalization="8.17M"
moving_average_200_day="0.86"
moving_average_50_day="0.65"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="6.00"
open="0.59"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-28.82%"
percent_change_from_50_day_moving_average="-5.71%"
percent_change_from_52_week_high="-61.14%"
percent_change_from_52_week_low="+19.61%"
previous_close="0.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.14"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="13400000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="XTLB"
volume="21189"
weeks_range_52="0.51 - 1.57"
